newsfilter
← Latest News
GlobeNewswire·

Entasis Therapeutics to Participate in H.C. Wainwright BioConnect 2022

WALTHAM, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX), a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that the Compa